Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rituximab-combined anthracycline-free chemotherapy in newly diagnosed paediatric and adolescent patients with non-high-risk aggressive mature B cell lymphoma: protocol for a single-arm, open-label, multicentre, phase II study (the Japan Children's Cancer Group Multicentre Trial, JPLSG B-NHL-20).
Sekimizu M, Fukano R, Koga Y, Mitsui T, Fujita N, Mori T, Hori D, Tanaka M, Ohki K, Iwafuchi H, Nakazawa A, Mori T, Kobayashi R, Hashimoto H, M Saito A, Kamei M; Lymphoma Committee of Japan Children’s Cancer Group. Sekimizu M, et al. Among authors: fukano r. BMJ Open. 2024 Mar 19;14(3):e080762. doi: 10.1136/bmjopen-2023-080762. BMJ Open. 2024. PMID: 38508620 Free PMC article.
Prognostic value of minimal disseminated disease assessed using digital polymerase chain reaction for 3'ALK assays in pediatric anaplastic lymphoma kinasepositive anaplastic large cell lymphoma.
Fukano R, Iijima-Yamashita Y, Iwafuchi H, Nakazawa A, Saito AM, Takimoto T, Sekimizu M, Suehiro Y, Yamasaki T, Hasegawa S, Mori T, Horibe K. Fukano R, et al. Haematologica. 2024 Feb 1;109(2):652-656. doi: 10.3324/haematol.2023.282812. Haematologica. 2024. PMID: 37675509 Free PMC article. No abstract available.
Low NUDT15 expression levels due to biallelic NUDT15 variants and 6-mercaptopurine intolerance.
Yoshida M, Brown SA, Moriyama T, Nishii R, Tsujimoto SI, Yamada Y, Yoshida K, Shirai R, Osumi T, Utano T, Fukano R, Kudo K, Sakaguchi K, Arakawa Y, Koh K, Sekiguchi M, Sekimizu M, Miyamura T, Ishida H, Inukai T, Tomizawa D, Kiyokawa N, Kato M, Yang JJ. Yoshida M, et al. Among authors: fukano r. Br J Haematol. 2022 Oct;199(2):270-276. doi: 10.1111/bjh.18375. Epub 2022 Jul 29. Br J Haematol. 2022. PMID: 35905175 Free PMC article.
BRAF V600E-positive cells as molecular markers of bone marrow disease in pediatric Langerhans cell histiocytosis.
Kudo K, Toki T, Kanezaki R, Tanaka T, Kamio T, Sato T, Sasaki S, Imamura M, Imai C, Ando K, Kakuda H, Doi T, Kawaguchi H, Irie M, Sasahara Y, Tamura A, Hasegawa D, Itakura Y, Watanabe K, Sakamoto K, Shioda Y, Kato M, Kudo K, Fukano R, Sato A, Yagasaki H, Kanegane H, Kato I, Umeda K, Adachi S, Kataoka T, Kurose A, Nakazawa A, Terui K, Ito E. Kudo K, et al. Among authors: fukano r. Haematologica. 2022 Jul 1;107(7):1719-1725. doi: 10.3324/haematol.2021.279857. Haematologica. 2022. PMID: 35295077 Free PMC article. No abstract available.
G3BP2-KIT drives leukemia amenable to kinase inhibition in Ph-like ALL.
Iacobucci I, Fukano R, D Friske J, Qu C, Janke LJ, Zhao Y, Baviskar P, A Backhaus E, Chockley P, Seth A, Laird AD, Advani AS, Mullighan CG. Iacobucci I, et al. Among authors: fukano r. Blood Adv. 2022 Jun 14;6(11):3255-3259. doi: 10.1182/bloodadvances.2021004854. Blood Adv. 2022. PMID: 34991158 Free PMC article. No abstract available.
73 results